Skip to main content

ManuCyte

Self-learning modular manufacturing platform for flexible, patient specific cell production

Project data

External identifier
FP7 260100
Cost
€ 3.435.700

ManuCyte focuses on the development of an intelligent, modular manufacturing platform for flexible, patient-specific cell production which will increase efficiency of personalised cell production in terms of quality, throughput, and costs. This objective will be reached by combining several high-sophisticated technologies such as

  • a modular and scalable concept for the setup of cell production platforms, which is based on plug-ins and allows a flexible composition of functionalities, extension of capacities, as well as fast ramp up.
  • a micro-fluidic component which provides cell culture medium specifically customised for each cell culture.
  • bioreactors with integrated sensor technology, which are capable for highly automated processes as well as the associated incubation component
  • the application of a cost-neutral cleanroom and sterilisation concept to keep cell cultures free of contaminations from the environment and between different cell cultures.
  • optical and biochemical inline monitoring methodologies, which enable the evaluation of cell status within the production process
  • a MES (Manufacturing Execution System) with LIMS (Laboratory Information and Management System) functionalities
  • a self-learning knowledge-based cell behaviour model and advanced cell process control functionalities.

Participants

  • ÅBO AKADEMI University
  • acp-IT AG
  • AFT GmbH
  • Chip-Man Technologies Oy
  • Fraunhofer IPA (project leader)
  • mta automation ag
  • MTA SZTAKI
  • PRIMACYT GmbH
  • Regensburg University of Applied Sciences

Manager

Members

György Kovács